Cargando…
Frequency of Renal Monitoring — Creatinine and Cystatin C (FORM-2C): an observational cohort study of patients with reduced eGFR in primary care
BACKGROUND: Monitoring is the mainstay of chronic kidney disease management in primary care; however, there is little evidence about the best way to do this. AIM: To compare the effectiveness of estimated glomerular filtration rate (eGFR) derived from serum creatinine and serum cystatin C to predict...
Autores principales: | Fleming, Susannah, Perera-Salazar, Rafael, Taylor, Kathryn S, Jones, Louise, Hobbs, FD Richard, James, Tim, O’Callaghan, Chris A, Shine, Brian, Verbakel, Jan Y, Stevens, Richard, Bankhead, Clare |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Royal College of General Practitioners
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8279657/ https://www.ncbi.nlm.nih.gov/pubmed/34048360 http://dx.doi.org/10.3399/BJGP.2020.0940 |
Ejemplares similares
-
Improved estimation of glomerular filtration rate (GFR) by comparison of eGFR(cystatin C) and eGFR(creatinine)
por: Grubb, Anders, et al.
Publicado: (2012) -
Potential relationship between eGFR(cystatin C)/eGFR(creatinine)‐ratio and glomerular basement membrane thickness in diabetic kidney disease
por: Öberg, Carl M., et al.
Publicado: (2021) -
eGFR(cystatinC)/eGFR(creatinine) ratio < 0.6 in patients with SARS-CoV-2 pneumonia: a prospective cohort study
por: Avotins, Lauris, et al.
Publicado: (2023) -
Cystatin C and creatinine-based eGFR levels and their correlation to long-term morbidity and mortality in older adults
por: Werner, Karin, et al.
Publicado: (2018) -
Medication-related adverse events in patients with cancer and discrepancies in cystatin C- versus creatinine-based eGFR
por: Hanna, Paul E., et al.
Publicado: (2023)